China's Pharma Contractors Thrive Amid US Supply Chain Tensions The resilience of China's pharmaceutical contractors in the face of Washington's push to curb their reliance on Chinese supply chains has sent shockwaves through the industry.
Recent financial reports from companies like Genscript and WuXi AppTec reveal a remarkable ability to adapt and thrive despite the headwinds.
Their success can be attributed, at least in part, to the deep seated cost advantages that China's pharmaceutical contractors have long enjoyed.